Continuous Glucose Monitoring Nears Mainstream Consumer Wearables
Manufacturers are racing to bring non-invasive continuous glucose monitoring capability into mainstream consumer wearables, a feature previously confined to dedicated medical devices requiring skin-penetrating sensors and prescription access. Early non-invasive prototypes have demonstrated accuracy within 15 percent of laboratory reference standards in controlled trials, though regulatory clearance for consumer marketing claims remains pending in most major markets. This capability, once cleared, would represent the largest single feature addition to the category since heart rate monitoring became standard, potentially triggering a broad upgrade cycle across the installed base. Investors are watching this regulatory pathway closely for early signals.
Market Impact: Programs cover over 10 million members








